AC069368.3 | Uncharacterized protein | | | | | | Tissue enhanced |
AC079602.1 | | | | | | | Tissue enhanced |
AC090616.2 | Uncharacterized protein | Predicted secreted proteins
| | | | | Tissue enhanced |
AC091801.1 | LOC392621; Uncharacterized protein | | | | | | Tissue enhanced |
AC092850.1 | Protein LOC100996701 | | | | | | Tissue enhanced |
AC093677.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC103801.2 | | | | | | | Tissue enhanced |
AC104534.3 | Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial | | | | | | Tissue enhanced |
AC105020.1 | Uncharacterized protein; cDNA FLJ12988 fis, clone NT2RP3000080 | | | | | | Tissue enhanced |
AC110619.2 | Uncharacterized protein | | | | | | Tissue enhanced |
AC114494.1 | HCG1787699; Uncharacterized protein | | | | | | Tissue enhanced |
AC114546.1 | HCG37415; PRO1914; Uncharacterized protein | | | | | | Tissue enhanced |
AC115618.1 | Uncharacterized protein; cDNA FLJ26048 fis, clone PRS02384 | | | | | | Tissue enhanced |
AC117395.1 | LOC646903 protein; Uncharacterized protein | | | | | | Tissue enhanced |
AC117834.1 | | | | | | | Tissue enhanced |
AC120194.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
AC129492.6 | | | | | | | Tissue enhanced |
AC131097.4 | Protein LOC285095 | | | | | | Tissue enhanced |
AC136297.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC138517.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AC142381.1 | | | | | | | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACER2 | Alkaline ceramidase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ACOT4 | Acyl-CoA thioesterase 4 | Enzymes
| | | | | Tissue enhanced |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes
| | | | | Tissue enhanced |
ACPT | Acid phosphatase, testicular | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ACRC | Acidic repeat containing | | | | | | Tissue enhanced |
ACSBG1 | Acyl-CoA synthetase bubblegum family member 1 | Enzymes
| | | | | Tissue enhanced |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACSM1 | Acyl-CoA synthetase medium-chain family member 1 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACSM3 | Acyl-CoA synthetase medium-chain family member 3 | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
ACTG2 | Actin, gamma 2, smooth muscle, enteric | Cytoskeleton related proteins
| | | | | Tissue enhanced |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | | | | Tissue enhanced |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |